Projects

International

• Individual radiosensitivity of cancer patients and nuclear-chemical personnel
  Program: Inter-academic agreement
  Duration: 1. 1. 2013 – 31. 12. 2015

National

• Evaluation of 5G radiation induced genotoxicity and assessment of phytochemicals as modulator of radiation induced DNA damage and cancer
  Program: VEGA
  Duration: 1. 1. 2023 – 31. 12. 2026

• Study of genotoxic  effects from magnetic resonance imaging in human lymphocytes
  Program: VEGA
  Duration: 1. 1. 2023 – 31. 12. 2026

• Radiation-induced noncoding RNAs in mononuclear cells of umbilical cord blood
  Program: VEGA
  Duration: 1. 1. 2022 – 31. 12. 2025

• Mechanisms of impact of low intensity electromagnetic radiation on course of cancer disease
  Program: VEGA
  Duration: 1. 1. 2018 – 31. 12. 2021

• Radiation-induced preleukemic fusion genes in proliferating hematopoietic stem/progenitor cells of umbilical cord blood
  Program: VEGA
  Duration: 1. 1. 2018 – 31. 12. 2021

• Biomarkers for assessment of individual radiosensitivity in breast cancer therapy
  Program: VEGA
  Duration: 1. 1. 2017 – 31. 12. 2020

• DNA damage REsponse and preleukemic Clones in hematopoietic stem cells in diagnOstics, Risk estimation and treatment of peDiatric leukemia
  Program: SRDA
  Duration: 1. 7. 2016 – 30. 9. 2019

• Constitutive and induced DNA damage in hematopoietic cells for assessment of risk and optimizing treatment of childhood leukemia
  Program: VEGA
  Duration: 1. 1. 2015 – 31. 12. 2017

• Preleukemic gene fusions and DNA repair in umbilical cord blood cells
  Program: VEGA
  Duration: 1. 1. 2015 – 31. 12. 2017

• Molecular markers of DNA repair in cancer therapy
  Program: VEGA
  Duration: 1. 1. 2011 – 31. 12. 2014

• Implementation of radiobiological research of intensity-modulated proton therapy into clinical oncology practice
  Program: EU Structural Funds Research & Development
  Duration: 20. 10. 2010 – 31. 3. 2014